市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Lantern Pharma Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.6
| 分析师共识 | 2.0 |
| 内部交易活动 | NA |
| 价格波动 | 3.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -2.5 |
| 平均 | 0.63 |
|
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group’s growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 14.10% |
| 机构持股比例 | 21.12% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Bios Capital Management, Lp | 31 Dec 2025 | 1,009,507 |
| Voss Capital, Lp | 31 Dec 2025 | 50,000 |
| Newedge Advisors, Llc | 31 Dec 2025 | 38,069 |
| Westside Investment Management, Inc. | 31 Dec 2025 | 35,900 |
| Horizon Kinetics Asset Management Llc | 31 Dec 2025 | 27,582 |
| Davenport & Co Llc | 31 Dec 2025 | 23,814 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合